Prevalence of human papillomavirus genotypes in northern taiwanese women

Journal of Medical Virology

Volumn 82, Issue 10, 2010, Pages 1739-1745

  Tsao, Kuo Chien ^a,b   Huang, Chung Guei ^a,b   Kuo, Yung Bin ^c   Chang, Ting Chang ^a,d   Sun, Chien Feng ^a,d   Allen Chang, C ^c,e   Yang, Su Li ^a   Chan, Err Cheng ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Distribution; Genotype; Human papillomavirus

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; DNA HYBRIDIZATION; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 58; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PREVALENCE; TAIWAN; UTERINE CERVICITIS; UTERINE CERVIX CYTOLOGY; WART VIRUS;

ADOLESCENT; ADULT; AGED; CERVIX UTERI; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; TAIWAN; VAGINAL SMEARS; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

EID: 77956601079     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21870     Document Type: Article

References (50)

1. Becker TM, Wheeler CM, McGough NS, Parmenter CA, Jordan SW, Stidley CA, McPherson RS, Dorin MH. 1994. Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern Hispanic and non-Hispanic white women. JAMA 271:1181-1188. (Pubitemid 24112998)
2. Bello BD, Spinillo A, Alberizzi P, Cesari S, Gardella B, D'Ambrosio G, Roccio M, Silini EM. 2009. Cervical infections by multiple human papillomavirus (HPV) genotypes: Prevalence and impact on the risk of precancerous epithelial lesions. J Med Virol 81:703-712.
3. Bernard HU. 2005. The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses. J Clin Virol 32:S1-S6.
4. Bernard HU, Calleja-Macias IE, Dunn ST. 2006. Genome variation of human papillomavirus types: Phylogenetic and medical implications. Int J Cancer 118:1071-1076.
5. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. 1995. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87:796-802.
6. Burd EM. 2003. Human papillomavirus and cervical cancer. Clin Microbiol Rev 16:1-17.
7. Chao A, Hsu KH, Lai CH, Huang HJ, Hsueh S, Lin SR, Jung SM, Chao FY, Huang SL, Huang CC, Yang JE, Chang TC. 2008. Cervical cancer screening program integrating Pap smear and HPV DNA testing: A population-based study. Int J Cancer 122:2835-2841. (Pubitemid 351631387)
8. Clifford GM, Smith JS, Aguado T, Franceschi S. 2003. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: A meta-analysis. Br J Cancer 89:101-105. (Pubitemid 36897943)
9. Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjose S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi S. 2005. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: A pooled analysis. Lancet 366:991-998. (Pubitemid 41323035)
10. de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, Bosch FX. 2007. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis. Lancet Infect Dis 7:453-459. (Pubitemid 46962343)
11. Fife KH, Cramer HM, Schroeder JM, Brown DR. 2001. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J Med Virol 64:550-559.
12. Forslund O, Antonsson A, Edlund K, van den Brule AJ, Hansson BG, Meijer CJ, Ryd W, Rylander E, Strand A, Wadell G, Dillner J, Johansson B. 2002. Population-based type-specific prevalence of high-risk human papillomavirus infection in middle-aged Swedish women. J Med Virol 66:535-541. (Pubitemid 34203245)
13. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, Jenkins D, Schuind A, Costa Clemens SA, Dubin G. 2006. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: Follow-up from a randomised control trial. Lancet 367:1247-1255.
14. Herrington CS, Evans MF, Charnock FM, Gray W, McGee JO'D. 1996. HPV testing in patients with low grade cervical cytological abnormalities: A follow up study. J Clin Pathol 49:493-496. (Pubitemid 26226541)
15. Hildesheim A, Gravitt P, Schiffman MH, Kurman RJ, Barnes W, Jones S, Tchabo JG, Brinton LA, Copeland C, Epp J, Manos MM. 1993. Determinants of genital human papillomavirus infection in low-income women in Washington, DC. Sex Transm Dis 20:279-285. (Pubitemid 23286958)
16. Huang S, Afonina I, Miller BA, Beckmann AM. 1997. Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. Int J Cancer 70:408-411. (Pubitemid 27107267)
17. Huang HJ, Huang SL, Lin CY, Lin RW, Chao FY, Chen MY, Chang TC, Hsueh S, Hsu KH, Lai CH. 2004. Human papillomavirus genotyping by a polymerase chain reaction-based genechip method in cervical carcinoma treated with neoadjuvant chemotherapy plus radical surgery. Int J Gynecol Cancer 14:639-649.
18. Huang SL, Chao A, Hsueh S, Chao FY, Huang CC, Yang JE, Lin CY, Yan CC, Chou HH, Huang KG, Huang HJ, Wu TI, Tseng MJ, Qiu JT, Lin CT, Chang TC, Lai CH. 2006. Comparison between the Hybrid Capture II Test and an SPF1/GP6+ PCR-based assay for detection of human papillomavirus DNA in cervical swab samples. J Clin Microbiol 44:1733-1739.
19. Jeng CJ, Ko ML, Ling QD, Shen J, Lin HW, Tzeng CR, Ho CM, Chien TY, Chen SC. 2005. Prevalence of cervical human papillomavirus in Taiwanese women. Clin Invest Med 28:261-266.
20. Kim JJ, Wright TC, Goldie SJ. 2005. Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy. J Natl Cancer Inst 97:888-895.
21. Kiviat NB, Koutsky LA, Critchlow CW, Lorincz AT, Cullen AP, Brockway J, Holmes KK. 1992. Prevalence and cytologic manifestations of human papilloma virus (HPV) types 6, 11,16, 18, 31, 33, 35, 42, 43, 44, 45, 51, 52, and 56 among 500 consecutive women. Int J Gynecol Pathol 11:197-203.
22. Kjaer SK, van den Brule AJ, Paull G, Svare EI, Sherman ME, Thomsen BL, Suntum M, Bock JE, Poll PA, Meijer CJ. 2002. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. Br Med J 325:572.
23. Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA. 2002. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: Comparison of sensitivity, specificity, and frequency of referral. JAMA 288:1749-1757.
24. Lai HC, Sun CA, Yu MH, Chen HJ, Liu HS, Chu TY. 1999. Favorable clinical outcome of cervical cancers infected with human papilloma virus type 58 and related types. Int J Cancer 84:553-557.
25. Lai CH, Huang HJ, Hsueh S, Chao A, Lin CT, Huang SL, Chao FY, Qiu JT, Hong JH, Chou HH, Chang TC, Chang CJ. 2007. Human papillomavirus genotype in cervical cancer: A population-based study. Int J Cancer 120:1999-2006.
26. Lin H, Ma YY, Moh JS, Ou YC, Shen SY, ChangChien CC. 2006. High prevalence of genital human papillomavirus type 52 and 58 infection in women attending gynecologic practitioners in South Taiwan. Gynecol Oncol 101:40-45.
27. Lin CY, Chao A, Yang YC, Chou HH, Ho CM, Lin RW, Chang TC, Chiou JY, Chao FY, Wang KL, Chien TY, Hsueh S, Huang CC, Chen CJ, Lai CH. 2008. Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR. J Clin Virol 42:361-367.
28. Matos E, Loria D, Amestoy GM, Herrera L, Prince MA, Moreno J, Krunfly C, van den Brule AJ, Meijer CJ, Munoz N, Herrero R. 2003. Prevalence of human papillomavirus infection among women in Concordia, Argentina: A population-based study. Sex Transm Dis 30:593-599.
29. Meijer CJ, Snijders PJ, Castle PE. 2006. Clinical utility of HPV genotyping. Gynecol Oncol 103:12-17.
30. Molijn A, Kleter B, Quint W, van Doorn LJ. 2005. Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol 32:S43-S51.
31. Morrison EA, Ho GY, Vermund SH, Goldberg GL, Kadish AS, Kelley KF, Burk RD. 1991. Human papillomavirus infection and other risk factors for cervical neoplasia: A case-control study. Int J Cancer 49:6-13.
32. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527. (Pubitemid 36159887)
33. Munoz N, Bosch FX, Castellsague X, Diaz M, de Sanjose S, Hammouda D, Shah KV, Meijer CJ. 2004. Against which human papillomavirus types shallwe vaccinate and screen? The international perspective. Int J Cancer 111:278-285.
34. Parkin DM, Bray F, Ferlay J, Pisani P. 2001. Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153-156.
35. Poljak M, Marin IJ, Seme K, Vince A. 2002. Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail. J Clin Virol 25:S89-S97.
36. Rousseau MC, Villa LL, Costa MC, Abrahamowicz M, Rohan TE, Franco E. 2003. Occurrence of cervical infection with multiple human papillomavirus types is associated with age and cytologic abnormalities. Sex Transm Dis 30:581-587.
37. Sebbelov AM, Davidson M, Kruger Kjaer S, Jensen H, Gregoire L, Hawkins I, Parkinson AJ, Norrild B. 2000. Comparison of human papillomavirus genotypes in archival cervical cancer specimens from Alaska natives, Greenland natives and Danish Caucasians. Microbes Infect 2:121-126.
38. Solomon D. 1991. The Bethesda System for reporting cervical/vaginal cytologic diagnosis: An overview. Int J Gynecol Pathol 10:323-325.
39. Solomon D, Schiffman M, Tarone R. 2001. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. J Natl Cancer Inst 93:293-299. (Pubitemid 32219816)
40. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Jr., Young N. 2002. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 287:2114-2119.
41. Sun CA, Hsiung CA, Lai CH, Chen CA, Chou CY, Ho CM, Twu NF, Feng WL, Chuang MH, Hsieh CY, Chu TY. 2005. Epidemiologic correlates of cervical human papillomavirus prevalence in women with abnormal Pap smear tests: A Taiwan Cooperative Oncology Group (TCOG) study. J Med Virol 77:273-281.
42. Tay SK, Ngan HY, Chu TY, Cheung AN, Tay EH. 2008. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan. Vaccine 26:M60-M70.
43. Trottier H, Franco EL. 2006. The epidemiology of genital human papillomavirus infection. Vaccine 24:S1-S15.
44. Trottier H, Mahmud S, Costa MC, Sobrinho JP, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL. 2006. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 15:1274-1280.
45. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ. 2002. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 40:779-787.
46. van Doorn LJ, Quint W, Kleter B, Molijn A, Colau B, Martin MT, Kravang I, Torrez-Martinez N, Peyton CL, Wheeler CM. 2002. Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay. J Clin Microbiol 40:979-983.
47. van Muyden RC, ter Harmsel BW, Smedts FM, Hermans J, Kuijpers JC, Raikhlin NT, Petrov S, Lebedev A, Ramaekers FC, Trimbos JB, Kleter B, Quint WG. 1999. Detection and typing of human papillomavirus in cervical carcinomas in Russian women: A prognostic study. Cancer 85:2011-2016.
48. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.
49. Wheeler CM, Parmenter CA, Hunt WC, Becker TM, Greer CE, Hildesheim A, Manos MM. 1993. Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico student health center. Sex Transm Dis 20:286-289.
50. zur Hausen H. 2000. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92:690-698.